Results 321 to 330 of about 303,204 (352)

[Preclinical/toxicologic evaluation of drugs].

Ugeskrift for laeger, 1999
Knudsen, Lisbeth E., Spindler, Per, Renneberg, Jan   +2 more
openaire   +1 more source

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Innovations in research and clinical care using patient‐generated health data

Ca-A Cancer Journal for Clinicians, 2020
H S L Jim, Aasha I Hoogland, Naomi C Brownstein   +2 more
exaly  

Preclinical Drug Safety Evaluation

2011
openaire   +1 more source

Preclinical Drug Safety Evaluation

2008
openaire   +1 more source

Current recommendations and recent progress in endometrial cancer

Ca-A Cancer Journal for Clinicians, 2019
Gini F Fleming
exaly  

Preclinical Drug Safety Evaluation

2016
openaire   +1 more source

Recent progress in pancreatic cancer

Ca-A Cancer Journal for Clinicians, 2013
Christopher L Wolfgang, Daniel A Laheru, Elliot Fishman   +2 more
exaly  

Hodgkin lymphoma: A review and update on recent progress

Ca-A Cancer Journal for Clinicians, 2018
Satish P Shanbhag, Richard F Ambinder
exaly  

[Preclinical evaluation of anticancer drugs: a model remaining a model!].

Bulletin du cancer, 1998
Two criteria are firstly used in the selection of new anticancer agents:--originality of the mechanism of action and significant experimental antitumor activity in an in vivo animal model. Murine tumors grafted in syngenic mice and human tumor xenografts implanted in nude mice are old models which continue to be widely used.
openaire   +1 more source